Other drugs include Metformin, Sulfonylureas, Glinides, Dipeptidyl peptidase-4 (DPP-4) inhibitors54,55 and glucagon like peptide-1 (GLP-1) receptor agonists etc. Since, protein, DNA and lipid glycation is a major pathological event associated with diabetes, our results indicate that organosulfurs should be employed as anti-glycating agent. The gene discussed is DPP4; the disease is diabetes mellitus.